Cytotoxic conjugates comprising a chemokine receptor targeting agent

Details for Australian Patent Application No. 2007201749 (hide)

Owner Osprey Pharmaceuticals Limited

Inventors McDonald, John R; Coggins, Phillip J

Agent Spruson & Ferguson

Pub. Number AU-B-2007201749

Parent 2007200061

Filing date 19 April 2007

Wipo publication date 10 May 2007

Acceptance publication date 29 May 2008

International Classifications

C07K 14/195 (2006.01) Peptides having more than 20 amino acids - from bacteria

C07K 14/52 (2006.01) Peptides having more than 20 amino acids

Event Publications

10 May 2007 Application Open to Public Inspection

  Published as AU-B-2007201749

10 May 2007 Complete Application Filed

29 May 2008 Application Accepted

  Published as AU-B-2007201749

3 July 2008 Application for Amendment

  The nature of the amendment is: Amend the name of the inventor to read: FROM: Coggins, Phillip J. TO: Coggins, Philip J. . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

14 August 2008 Assignment before Grant

  Osprey Pharmaceuticals Limited The application has been assigned to Osprey Pharmaceuticals USA, Inc.

23 October 2008 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read FROM: Coggins, Phillip J. TO: Coggins, Philip J.

30 October 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007201750-An Improved Sink

2007201748-Local regional chemotherapy and radiotherapy using in situ hydrogel